PCV (pneumococcal conjugate vaccine) 13 Clinical Trials
4 recruitingBiologic
Phase 34
Showing 1–4 of 4 trials
Recruiting
Phase 3
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age
Chickenpox
GlaxoSmithKline900 enrolled12 locationsNCT06855160
Recruiting
Phase 3
A Study on the Immune Response and Safety of the Second Dose of an Investigational Chickenpox Vaccine When Given to Healthy Children 3 Months After a First Dose at 12 to 15 Months of Age
Chickenpox
GlaxoSmithKline600 enrolled3 locationsNCT06806137
Recruiting
Phase 3
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age
Chickenpox
GlaxoSmithKline1,840 enrolled5 locationsNCT06740630
Recruiting
Phase 3
A Study on the Safety of an Investigational Chickenpox Vaccine, When Given to Healthy Children, 12 to 15 Months of Age
Chickenpox
GlaxoSmithKline750 enrolled1 locationNCT06693895